Connect with us

Health

Scientists identify key driver in BRAF inhibitor resistant melanoma – News-Medical.Net

Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.

Published

on

Reviewed by Emily Henderson, B.Sc.Sep 2 2020
Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.
However, many patients become resistant to the therapy, and this can often lead to further metastasis. Moffitt Cancer Center researchers who helped develop this type of combination therapy are now working to better understand what leads to this resistance in hopes of devel…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending